Low-density lipoprotein cholesterol lowering therapy for the secondary prevention of atherosclerotic cardiovascular disease

Atherosclerotic cardiovascular disease (ASCVD) is highly prevalent and a major contributor to morbidity and mortality worldwide. Elevated blood cholesterol is a key driver of risk for atherosclerotic events, and patients with established ASCVD comprise a specific high-risk population in which low-de...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Parth N., Giugliano, Robert P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Magdi Yacoub Heart Foundation 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7868100/
https://www.ncbi.nlm.nih.gov/pubmed/33598499
http://dx.doi.org/10.21542/gcsp.2020.39

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7868100/
https://www.ncbi.nlm.nih.gov/pubmed/33598499
http://dx.doi.org/10.21542/gcsp.2020.39

Ejemplares similares